The DOI matches its Crossref record; 218 of the 228 references it cites were found in a registry or an index.
Microsatellite Instability in Colorectal Cancer
Open accessAbstract
Microsatellite instability (MSI) is a hypermutable phenotype caused by the loss of DNA mismatch repair activity. MSI is detected in about 15% of all colorectal cancers; 3% are of these are associated with Lynch syndrome and the other 12% are caused by sporadic, acquired hypermethylation of the promoter of the MLH1 gene, which occurs in tumors with the CpG island methylator phenotype. Colorectal tumors with MSI have distinctive features, including a tendency to arise in the proximal colon, lymphocytic infiltrate, and a poorly differentiated, mucinous or signet ring appearance. They have a slightly better prognosis than colorectal tumors without MSI and do not have the same response to chemotherapeutics. Discovery of MSI in colorectal tumors has increased awareness of the diversity of colorectal cancers and implications for specialized management of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“however, are commonly identified through separate MSI analysis and/or additional immunohistochemical staining for mismatch repair enzymes in pathology diagnostics2,3,51.”
From Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer (2025) · cites this paper as [51]
The cited source says what the claim attributes to it.
In the citing paper
“MSI-high tumors have been linked to a favorable prognosis2,51, characterized by lower differentiation grade, increased T-cell infiltration, and reduced susceptibility to invasiveness and KRAS mutation51”
From Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer (2025) · cites this paper as [51]
In the citing paper
“Microsatellite instability (MSI) caused by dysfunctional mismatch repair (dMMR) is detected in approximately 15% of all CRC and in nearly all cases with Lynch syndrome [126].”
From Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies (2021) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citationUmar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Self-citation
Cited by
Sorted by citations
Items 801–900 of 1,002
Ostwal, V. S., Pande, N., Engineer, R. Z., Saklani, A. P., Desouza, A. L., Ramadwar, M. R., Sawant, S., Mandavkar, S., Shrirangwar, S., Kataria, P., et al. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2018.10.01 · Cited by 23
Fricke, F., Mussack, V., Buschmann, D., Haußer, I., Pfaffl, M. W., Kopitz, J., & Gebert, J. F. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4859 · Cited by 22
Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer
Chen, P., Xu, J., Cui, Z., Wu, S., Xie, T., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1071675 · Cited by 22
Nanoparticles Containing Oxaliplatin and the Treatment of Colorectal Cancer
Mahaki, H., Mansourian, M., Meshkat, Z., Avan, A., Shafiee, M. H., Mahmoudian, R. A., Ghorbani, E., Ferns, G. A., Manoochehri, H., Menbari, S., et al. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128274742231103063738 · Cited by 25
Ding, D., Liang, R., Li, T., Lan, T., Li, Y., Huang, S., He, G., Ren, J., Li, W., Zheng, Z., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.052 · Cited by 22
Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status
Chirica, M., Bourhis, L. L., Lehmann‐Che, J., Chardiny, V., Bouhidel, F. A., Foulboeuf, L., Gornet, J. M., Lourenço, N., Dulphy, N., Toubert, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1016698 · Cited by 22
Stratification and Prognostic Relevance of Jass’s Molecular Classification of Colorectal Cancer
Zlobec, I., Bihl, M., Foerster, A., Rufle, A., Terracciano, L., & Lugli, A. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00007 · Cited by 22
Functional impact of colorectal cancer-associated mutations in the transcription factor E2F4
Paquin, M., Leblanc, C., Lemieux, É., Bian, B., & Rivard, N. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2131 · Cited by 22
Jascur, T. A., Fotedar, R., Greene, S., Hotchkiss, E. C., & Boland, C. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221341 · Cited by 23
Self-citationPersonalized treatment for colorectal cancer: novel developments and putative therapeutic strategies
Akkad, J., Bochum, S., & Martens, U. M. (2015) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-015-1276-0 · Cited by 22
Miller, S., Senior, P. V., Prakash, M. D., Apostolopoulos, V., Sakkal, S., & Nurgali, K. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw002 · Cited by 23
Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer
Yang, L., Chen, P., Zhang, L., Wang, L., Sun, T., Zhou, L., Li, Z., & Wu, A. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0974-8 · Cited by 22
Liu, Y. L., & Weigelt, B. (2024) · Cancer · doi:10.1002/cncr.35267 · Cited by 22
Personalized treatment for advanced colorectal cancer: KRAS and beyond
Karapetis, C. S., & Patel, G. S. (2013) · Cancer Management and Research · doi:10.2147/cmar.s35025 · Cited by 20
Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action
Kline, C., & El‐Deiry, W. S. (2013) · Pharmaceuticals · doi:10.3390/ph6080988 · Cited by 24
Predictive Biomarkers for PD-1 and PD-L1 Immune Checkpoint Blockade Therapy
Song, Y., Li, Z., Xue, W., & Zhang, M. (2019) · Immunotherapy · doi:10.2217/imt-2018-0173 · Cited by 21
Rasmussen, M., Madsen, M. G., & Therkildsen, C. (2022) · Urology · doi:10.1016/j.urology.2022.02.006 · Cited by 21
Yu, G., Wang, W., He, X., Xu, J. M., Xu, R., Wan, T., & Wu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.895103 · Cited by 22
Mkrtchyan, G. V., Veviorskiy, A., Izumchenko, E., Shneyderman, A., Pun, F. W., Ozerov, I. V., Aliper, A., Zhavoronkov, A. A., & Scheibye‐Knudsen, M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05437-w · Cited by 23
Chen, J., Yan, Q., Sun, J., Wang, Q., Tao, Y., Xiao, D., & Xie, B. (2023) · Journal of Cancer · doi:10.7150/jca.81675 · Cited by 21
Radiologic T staging of colon cancer: renewed interest for clinical practice
Chang, K. J., Kim, D. H., Lalani, T., Paroder, V., Pickhardt, P. J., Shaish, H. A., & Bates, . D. B. (2023) · Abdominal Radiology · doi:10.1007/s00261-023-03904-2 · Cited by 21
Wang, Y., Yang, S., Wan, L., Ling, W., Chen, H. H., & Wang, J. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5534 · Cited by 22
Lee, D., Han, S., Cha, Y., Rhee, Y.-Y., Bae, J. M., Cho, N., Lee, K.-H., Kim, T. Y., Oh, D., Im, S., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0106-0 · Cited by 21
Huang, S. C., Durno, C. A., & Erdman, S. H. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000179 · Cited by 21
Mokarram, P., Rismanchi, M., Naeeni, M. A., Samiee, S. M., Paryan, M., Alipour, A., Honardar, Z., Kavousipour, S., Naghibalhossaini, F., Mostafavi‐Pour, Z., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3138-1 · Cited by 20
Tumor budding as a potential histopathological biomarker in colorectal cancer: Hype or hope?
Grizzi, F. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i45.6532 · Cited by 21
Molecular Mechanisms of Colorectal Carcinogenesis
Roper, J., & Hung, K. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8412-7_2 · Cited by 22
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
Peters, M. L. B., Tseng, J. F., & Miksad, R. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.006 · Cited by 21
Jang, M., Kwon, Y., Kim, H., Kim, H., Min, B. S., Park, Y., Kim, T. I., Hong, S. P., & Kim, W. K. (2018) · BMC Cancer · doi:10.1186/s12885-018-5127-6 · Cited by 21
Yalçın, M., El‐Athman, R., Ouk, K., Priller, J., & Relógio, A. (2020) · Cancers · doi:10.3390/cancers12040963 · Cited by 21
Zhang, R., Feng, Y., Ma, W., Guo, Y., Luo, M., Li, Y., Zang, Y., Dong, X., Lu, S., Guo, Q., et al. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.01.036 · Cited by 19
Genetic Mechanisms in Interval Colon Cancers
Richter, J. M., Pino, M. S., Austin, T. R., Campbell, E. J., Szymonifka, J. D., Russo, A. L., Hong, T. S., Borger, D. R., Iafrate, A. J., & Chung, D. C. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3134-2 · Cited by 21
Kullmann, F., Strissel, P. L., Strick, R., Stoehr, R., Eckstein, M., Bertz, S., Wullich, B., Sikic, D., Wach, S., Taubert, H., et al. (2023) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207855 · Cited by 20
Tolerance of Oncogene-Induced Replication Stress: A Fuel for Genomic Instability
Igarashi, T., Yano, K., Endo, S., & Shiotani, B. (2024) · Cancers · doi:10.3390/cancers16203507 · Cited by 22
Imtiaz, I. R., Schloss, J. M., & Bugarc̀ić, A. (2025) · Biomolecules · doi:10.3390/biom15030380 · Cited by 20
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
Mazloom, A., Ghalehsari, N., Gazivoda, V. P., Nimkar, N., Paul, S., Gregos, P., Rateshwar, J., & Khan, U. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082533 · Cited by 21
Haupt, S., Zeilmann, A., Ahadova, A., Bläker, H., Doeberitz, M. V. K., Kloor, M., & Heuveline, V. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008970 · Cited by 20
Wang, X., Zhang, J., Hu, B., & Qian, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.850767 · Cited by 20
RecQ Helicase Somatic Alterations in Cancer
Thakkar, M. K., Lee, J., Meyer, S., & Chang, V. Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.887758 · Cited by 22
Liu, Y., Gusev, A., & Kraft, P. L. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2624 · Cited by 19
Abboud, K., Umoru, G., Esmail, A., Abudayyeh, A., Murakami, N., Al-Shamsi, H. O., Javle, M. M., Saharia, A., Connor, A. A., Kodali, S., et al. (2023) · Cancers · doi:10.3390/cancers15051433 · Cited by 21
Sharma, S., Singh, N., Turk, A. A., Wan, I., Guttikonda, A., Dong, J. L., Zhang, X., & Opyrchal, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i13.1815 · Cited by 22
Biological and Clinical Characteristics of Proximal Colon Cancer: Far from Its Anatomical Subsite
Yang, Q. Z., Qu, R., Lu, S., Zhang, Y., Zhang, Z., & Fu, W. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.97574 · Cited by 20
Genetic instability in urinary bladder cancer
Wadhwa, N., Mathew, B. B., Jatawa, S. K., & Tiwari, A. (2013) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.123156 · Cited by 20
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
Malesci, A., Basso, G., Bianchi, P. P., Fini, L., Grizzi, F., Celesti, G., Caro, G. D., Delconte, G., Dattola, F., Repici, A., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.827 · Cited by 20
Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers
Piazzi, G., Selgrad, M., Garcia, M., Ceccarelli, C., Fini, L., Bianchi, P. P., Laghi, L., D'Angelo, L., Paterini, P., Malfertheiner, P., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.142 · Cited by 23
Self-citationMismatch repair deficiency in colorectal cancer patients in a low-incidence area.
Vergouwe, F. W. T., Boutall, A., Stupart, D. A., Algar, U., Govender, D., van der Linde, G. D., Mall, A. S., Ramesar, R., & Goldberg, P. A. (2013) · PubMed · doi:10.7196/sajs.1314 · Cited by 20
Razzak, A. A., Oxentenko, A. S., Vierkant, R. A., Tillmans, L. S., Wang, A. H., Weisenberger, D. J., Laird, P. W., Lynch, C. F., Anderson, K. E., French, A. J., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0276 · Cited by 20
The Genetics of Colorectal Cancer
Hankey, W., & Groden, J. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8412-7_1 · Cited by 21
Fini, L., Laghi, L., Hassan, C., Pestalozza, A., Pagano, N., Balzarini, L., Repici, A., Pickhardt, P. J., & Malesci, A. (2013) · Radiology · doi:10.1148/radiol.13130373 · Cited by 20
Nakano, K., Yamamoto, H., Fujiwara, M., Koga, Y., Tsuruta, S., Ihara, E., Oki, E., Nakamura, M., Ogawa, Y., & Oda, Y. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000947 · Cited by 20
Zhang, T., Huang, T., & Wang, R. (2018) · Oncology Letters · doi:10.3892/ol.2018.8860 · Cited by 20
Gene expression profiles in genome instability-based classes of colorectal cancer
Barresi, V., Cinnirella, G., Valenti, G., Spampinato, G., Musso, N., Castorina, S., & Condorelli, D. F. (2018) · BMC Cancer · doi:10.1186/s12885-018-5174-z · Cited by 20
E3 ubiquitin ligase Smurf2: a prognostic factor in microsatellite stable colorectal cancer
Klupp, F., Giese, C., Halama, N., Franz, C., Lasitschka, F., Warth, A., Schmidt, T., Kloor, M., Ulrich, A. B., & Schneider, M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s178111 · Cited by 20
Redford, L., Alhilal, G., Needham, S. J., O’Brien, O., Coaker, J., Tyson, J. R., Amorim, L. M., Middleton, I., Izuogu, O. G., Arends, M. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203052 · Cited by 20
Watson, M. M., Kanani, A., Lea, D., Khajavi, R. B., Søreide, J. A., Kørner, H., Hagland, H. R., & Søreide, K. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08048-6 · Cited by 20
Almeida-Lousada, H., Mestre, A., Ramalhete, S., Price, A. J., de Mello, R. A., Marreiros, A., das Neves, R. P., & Castelo‐Branco, P. (2021) · Current Oncology · doi:10.3390/curroncol28060411 · Cited by 20
Biomarker-driven and molecular targeted therapies for colorectal cancers
Schirripa, M., Cohen, S. A., Battaglin, F., & Lenz, H. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.06.003 · Cited by 25
Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma
Kuwata, T. (2024) · Pathology International · doi:10.1111/pin.13427 · Cited by 22
New insight in immunotherapy and combine therapy in colorectal cancer
Ji, K., Jia, H., Liu, Z., Yu, G., Wen, R., Zhang, T., Peng, Z., Man, W., Tian, Y., Wang, C., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1453630 · Cited by 22
Kim, J. H., Bae, J. M., Kim, K.-J., Rhee, Y.-Y., Kim, Y.-H., Cho, N., Lee, H. S., Chang, M. S., & Kang, G. H. (2014) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2014.48.4.276 · Cited by 19
Xu, J., Bao, H., Wu, X., Wang, X., Shao, Y. W., & Sun, T. (2019) · Oncology Letters · doi:10.3892/ol.2019.10287 · Cited by 19
PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives
Gevaert, T., Cimadamore, A., Montironi, R., & Eckstein, M. (2020) · Current Drug Targets · doi:10.2174/1389450121666200510015216 · Cited by 19
Mathew, J. G., Bowman, A. S., Saab, J., BUSAM, K. J., Nehal, K. S., & Pulitzer, M. P. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.11.073 · Cited by 19
Mechanical signatures of human colon cancers
Lopez‐Crapez, E., Costa, L., Tosato, G., Ramos, J., Mazard, T., Guiramand, J., Thierry, A. R., Colinge, J., Milhiet, P., & Bénistant, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-16669-3 · Cited by 20
Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
Zhang, R., Wang, W., Zhang, N., Chen, X., Liu, W., Zhang, L., & Liu, N. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17517 · Cited by 18
Leiby, J. S., Hao, J., Kang, G. H., Park, J. W., & Kim, D. (2022) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc48229.2022.9871553 · Cited by 18
Interplay between the DNA Damage Response and Immunotherapy Response in Cancer
Lee, E. C. Y., Kok, J. S.-T., Teh, B. T., & Lim, K. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113356 · Cited by 22
Ranganathan, M., Sacca, R. E., Trottier, M., Maio, A., Kemel, Y. M., Salo‐Mullen, E. E., Catchings, A., Kane, S. R., Wang, C., Ravichandran, V., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00675 · Cited by 23
Rospo, G., Chilà, R., Matafora, V., Basso, V., Lamba, S., Bartolini, A., Bachi, A., Nicolantonio, F. D., Mondino, A., Germano, G., et al. (2024) · Genome Medicine · doi:10.1186/s13073-023-01275-3 · Cited by 19
Immunotherapy in colorectal cancer: Statuses and strategies
Li, Y., Cheng, Z., Li, S., & Zhang, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41354 · Cited by 24
Ezrin expression in rectal cancer predicts time to development of local recurrence
Jörgren, F., Nilbert, M. C., Rambech, E., Bendahl, P., & Lindmark, G. E. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1397-z · Cited by 19
Liu, X.-Q., Rajput, A., Geng, L., Ongchin, M. C., Chaudhuri, A., & Wang, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221697 · Cited by 19
RetractedExcision of translesion synthesis errors orchestrates responses to helix-distorting DNA lesions
Tsaalbi‐Shtylik, A., Ferrás, C., Pauw, B., Hendriks, G., Temviriyanukul, P., Carlée, L., Calléja, F. M. G. R., van Hees‐Stuivenberg, S., Akagi, J., Iwai, S., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201408017 · Cited by 20
Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas
Chen, J., Raju, G. S., Jogunoori, W. S., Menon, V. K., Majumdar, A., Chen, J., Gi, Y. J., Jeong, Y. S., Phan, L. M., Belkin, M. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153933 · Cited by 19
Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
Nghiem, B., Zhang, X., Lam, H., True, L. D., Coleman, I. M., Higano, C. S., Nelson, P. S., Pritchard, C. C., & Morrissey, C. M. (2016) · Asian journal of urology · doi:10.1016/j.ajur.2016.09.002 · Cited by 19
Savio, A. J., Mrkonjic, M., Lemire, M., Gallinger, S., Knight, J. A., & Bapat, B. V. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0326-6 · Cited by 19
XPD–The Lynchpin of NER: Molecule, Gene, Polymorphisms, and Role in Colorectal Carcinogenesis
Aga, S. S., & Nissar, S. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00023 · Cited by 20
Tryakin, A. A., Fedyanin, M. Y., Цуканов, А. С., Shelygin, Y. A., Покатаев, И. А., Ignatova, E., Хакимова, Г. Г., Frolova, M. A., & Tjulandin, S. (2020) · Malignant tumours · doi:10.18027/2224-5057-2019-9-4-59-69 · Cited by 19
Gunnarsson, U., Strigård, K., Edin, S., Gkekas, I., Mustonen, H. K., Kaprio, T., Böckelman, C., Hagström, J., Palmqvist, R., & Haglund, C. H. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02336-6 · Cited by 19
Absence of microsatellite instability in mucinous carcinomas of the breast.
Lacroix‐Triki, M., Lambros, M. B. K., Geyer, F. C., Suarez, P. H., Reis-Filho, J. S., & Weigelt, B. (2010) · PubMed Central · Cited by 19
Establishing a Biological Profile for Interval Colorectal Cancers
Cisyk, A. L., Singh, H., & McManus, K. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3210-7 · Cited by 19
Bailis, J. M., Weidmann, A. G., Mariano, N. F., & Barton, J. K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706665114 · Cited by 19
What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?
Peruhova, M., Peshevska-Sekulovska, M., Krastev, B. M., Panayotova, G. G., Georgieva, V., Konakchieva, R., Nikolaev, G., & Velikova, T. V. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i42.6556 · Cited by 18
Conlon, S. G., Khuu, C., Trasviña‐Arenas, C. H., Xia, T., Hamm, M. L., Raetz, A. G., & David, S. S. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c00784 · Cited by 18
Ashayeri, H., Sobhi, N., Pławiak, P., Pedrammehr, S., Alizadehsani, R., & Jafarizadeh, A. (2024) · Cancers · doi:10.3390/cancers16112138 · Cited by 21
Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases
Ahtiainen, M., Elomaa, H., Väyrynen, J. P., Wirta, E., Kuopio, T., Helminen, O., Seppälä, T. T., Kellokumpu, I., & Mecklin, J. (2021) · Cancers · doi:10.3390/cancers13071530 · Cited by 18
Impact of microsatellite status in early-onset colonic cancer
Collaborative, R., Zaborowski, A. M., Abdile, A., Aigner, F., d’Allens, L., Allmer, C., Álvarez, A., Anula, R., Andric, M., Bach, S. A. S., et al. (2022) · British journal of surgery · doi:10.1093/bjs/znac108 · Cited by 18
Fang, Z., Huang, H., Wang, L., & Lin, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.968984 · Cited by 18
Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
Jou, E., Rodríguez‐Rodríguez, N., & McKenzie, A. N. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981479 · Cited by 19
Ma, Y., Lin, C., Liu, S., Wei, Y., Ji, C., Shi, F., Lin, F., & Zhou, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1020349 · Cited by 18
Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy
Prakash, A., Gates, T. J., Zhao, X., Wangmo, D., & Subramanian, S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108332 · Cited by 19
Granata, V., Fusco, R., Setola, S. V., Galdiero, R., Maggialetti, N., Patrone, R., Ottaiano, A., Nasti, G., Silvestro, L., Cassata, A., et al. (2023) · Infectious Agents and Cancer · doi:10.1186/s13027-023-00495-x · Cited by 19
Proteomic Signature of Extracellular Vesicles Associated with Colorectal Cancer
Soloveva, N. A., Novikova, S. E., Farafonova, T. E., Tikhonova, O. V., & Zgoda, V. G. (2023) · Molecules · doi:10.3390/molecules28104227 · Cited by 19
Christenson, E. S., Tsai, H., Le, D. T., Jaffee, E. M., Dudley, J. C., Xian, R. R., Gocke, C. D., Eshleman, J. R., & Lin, M.-T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1193259 · Cited by 19
B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours
Mielcarska, S., Dawidowicz, M., Kula, A., Kiczmer, P., Skiba, H., Krygier, M., Chrabańska, M., Piecuch, J., Szrot, M., Ochman, B., et al. (2023) · Cancers · doi:10.3390/cancers15123136 · Cited by 18
The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer
Ding, K., Mou, P., Wang, Z., Liu, S., Liu, J., Lü, H., & Yu, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1298524 · Cited by 19
Li, Y., Tan, L., Chen, N., Liu, X., Liang, F., Yao, Y., Zhang, X. Y., & Wu, A. (2024) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000003290 · Cited by 20
Savio, A. J., Lemire, M., Mrkonjic, M., Gallinger, S., Zanke, B. W., Hudson, T. J., & Bapat, B. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051531 · Cited by 18
Colorectal cancer resection in the Australian nonagenarian patient
Schlichtemeier, S., Logaraj, A., Gill, A. J., & Engel, A. F. (2016) · Colorectal Disease · doi:10.1111/codi.13434 · Cited by 18
Metadata
- Authors
- Boland, C. R., & Goel, A.
- Affiliations
- Baylor University Medical Center (US)
- Corresponding author
- Boland, C. Richard
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 138
- Issue
- 6
- Pages
- 2073-2087.e3
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3037515
- OpenAlex
- W2094390470
- Cited by
- 2,456
- References
- 228
- Citations by year
- 2026: 140 · 2025: 201 · 2024: 202 · 2023: 191 · 2022: 257 · 2021: 211 · 2020: 194 · 2019: 160 · 2018: 140 · 2017: 115 · 2016: 112 · 2015: 117 · 2014: 111 · 2013: 100 · 2012: 94
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R01 CA129286, R01 CA72851)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, colorectal cancer, DNA mismatch repair, Lynch syndrome, MLH1 promoter methylation, CpG island methylator phenotype, proximal colon tumors, lymphocyte infiltration, mucinous tumors, signet ring cell carcinoma, prognosis, chemotherapy response
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Colorectal Neoplasms, Hereditary Nonpolyposis, Humans, Mutation, Phenotype, Risk Factors, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Treatment Outcome, Genetic Predisposition to Disease, Microsatellite Instability, DNA Mismatch Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review